Back to
JPMorgan Chase & Co.
AUTL
8 quarters
Position history for
JPMorgan Chase & Co.'s holdings in Autolus Therapeutics plc
Yes. JPMorgan Chase holds 913,239 shares of AUTL (Autolus Therapeutics), worth $1.5M, as of its Q2 2026 13F filing. It reduced the position by 22,164 shares (-2.4%) from Q1 2026. JPMorgan Chase has held AUTL in every 13F on record since Q3 2024, 8 quarterly filings.
Current Value
$1.5M
Current Shares
913,239
Total Value Change
-$3.2M
Total Shares Change
-371,469
Quarter-by-Quarter History
Other major holders of AUTL: Blackstone Inc., Wellington Management Group LLP, Avoro Capital Advisors LLC